Commentary

Page 12

Recently published articles about Commentary

PCC
Commentary

May 7, 2020

Could social isolation and fear generated by COVID-19 increase intimate partner violence? This commentary looks at the associations between the COVID-19 crisis and domestic violence and stresses the importance...
, ,
PCC
Commentary

April 30, 2020

In this commentary, the authors discuss the risks associated with use of hydroxychloroquine in COVID-19-infected patients with schizophrenia.
JCP
Commentary

April 28, 2020

Although the COVID-19 pandemic has impacted everyone in some way, those with serious mental illness (SMI) may face unique challenges. This commentary looks at the consequences of both the...
,
PCC
Commentary

April 16, 2020

In this commentary, the authors discuss the impact of COVID-19 on those with mental illness and in the field of psychiatry.
, ,
JCP
Commentary

April 14, 2020

Read commentary on the crisis in India due to the COVID-19 lockdown, including the ramifications for health care, food supply, economy, and daily life.
JCP
Commentary

April 14, 2020

Read commentary on the possibilities for treating patients who have suicidal thoughts and behaviors during the COVID-19 pandemic.
, , , et al
JCP
Commentary

April 7, 2020

During the COVID-19 pandemic, psychiatrists may respond to the "all hands on deck" call from health care institutions. This commentary looks at how expertise in distinguishing and managing normal...
JCP
Commentary

April 7, 2020

This commentary considers the ways in which resources related to psychiatry, including digital tools, clinical skills, and psychiatric medications, can be put to effective use in the context of...
, , , et al
JCP
Commentary

March 31, 2020

In this commentary, Dr Corruble gives an account from the front lines of treating psychiatric patients during the COVID-19 outbreak in Paris, France.
JCP
Commentary

March 31, 2020

In this commentary, the authors describe the hospital environment and the protective measures being taken during the COVID-19 pandemic in a hospital in Tuscany, Italy.
, ,
JCP
Commentary

March 3, 2020

Read commentary on the possible reasons why placebo response rates in clinical trials for schizophrenia are increasing.
JCP
Commentary

December 3, 2019

This commentary discusses the findings and implications of a recent post hoc study by Thase and colleagues on the utility of combinatorial pharmacogenomics in depression.

Consensus Report on XT Use in Practice

Read the full report
Figure: Graphic promoting Consensus Report on Xanomeline-Trospium; colorful net design shown with JCP logo in lower left.

Subscribe to read
more articles

Subscribe